Algunos aspectos relacionados con la implantación del desfibrilador automático implantable

1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202 Connolly, 2000, Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation, 101, 1297, 10.1161/01.CIR.101.11.1297 Kuck, 2000, Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resucitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH), Circulation, 102, 748, 10.1161/01.CIR.102.7.748 Moss, 1996, Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators, N Engl J Med, 335, 1933, 10.1056/NEJM199612263352601 Buxton, 1999, A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators, N Engl J Med, 341, 1882, 10.1056/NEJM199912163412503 Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399 Brugada, 1998, Enhanced detection criteria in implantable defibrillators, J Cardiovasc Electrophysiol, 9, 261, 10.1111/j.1540-8167.1998.tb00911.x Kettering, 2001, Enhanced detection criteria in implantable cardioverter defibrillators: sensitivity and specificity of the stability algorithm at different heart rates, Pacing Clin Electrophysiol, 24, 1325, 10.1046/j.1460-9592.2001.01325.x Dorian, 2004, Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator, Heart Rhythm, 1, 540, 10.1016/j.hrthm.2004.07.017 Kuhlkamp, 1999, Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing, J Cardiovasc Electrophysiol, 10, 905, 10.1111/j.1540-8167.1999.tb01261.x Deisenhofer, 2001, Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study, J Cardiovasc Electrophysiol, 12, 134, 10.1046/j.1540-8167.2001.00134.x Theuns, 2004, Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms, J Am Coll Cardiol, 44, 2362, 10.1016/j.jacc.2004.09.039 Grimm, 1992, Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators, Pacing Clin Electrophysiol, 15, 1667, 10.1111/j.1540-8159.1992.tb02953.x Schmitt, 1994, Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators, Pacing Clin Electrophysiol, 17, 295, 10.1111/j.1540-8159.1994.tb01391.x Theuns, 2005, Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy, Am J Cardiol, 95, 271, 10.1016/j.amjcard.2004.09.017 Bansch, 2004, The 1+1 Trial: a prospective trial of dual-versus single-chamber implantable defibrillator in patients with slow ventricular tachycardias, Circulation, 110, 1022, 10.1161/01.CIR.0000140259.16185.7D Friedman, 2006, Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis. The Detect Supraventricular Tachycardia Study, Circulation, 113, 2871, 10.1161/CIRCULATIONAHA.105.594531 Quesada, 2004, The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator, Europace, 6, 142, 10.1016/j.eupc.2003.11.011 Almendral, 2006, The DATAS trial: Clinically Significant Adverse Events in Single vs Dual Chamber ICD, Circulation, 114, II397 Ricci, 2002, Efficacy of a dual chamber defibrillator with trial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias, Eur Heart J, 23, 1471, 10.1053/euhj.2001.3154 Darbar, 2005, Recurrence of atrial tachyarrhythmias in implantable cardioverter-defibrillator recipients, Pacing Clin Electrophysiol, 28, 1047, 10.1111/j.1540-8159.2005.00222.x Takahashi, 2002, High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version, Circ J, 66, 746, 10.1253/circj.66.746 Nielsen, 2003, A randomized comparison of atrial and dualchamber pacing in 177 consecutive patients with sick sinus syndrome. Echocardiographic and clinical outcome, J Am Coll Cardiol, 42, 614, 10.1016/S0735-1097(03)00757-5 Kristensen, 2004, Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome, Heart, 90, 661, 10.1136/hrt.2003.016063 Adler, 2001, Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator, Circulation, 104, 887, 10.1161/hc3301.094739 Dries, 1998, J Am Coll Cardiol, 32, 695, 10.1016/S0735-1097(98)00297-6 Stein, 2002, Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?, J Am Coll Cardiol, 40, 335, 10.1016/S0735-1097(02)01957-5 Sweeney, 2006, A new paradigm for physiologic ventricular pacing, J Am Coll Cardiol, 47, 282, 10.1016/j.jacc.2005.09.029 2002, Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) trial, JAMA, 288, 3115, 10.1001/jama.288.24.3115 Sweeney, 2003, Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction, Circulation, 23, 2932, 10.1161/01.CIR.0000072769.17295.B1 Steinberg, 2005, The clinical implications of cumulative right ventricular pacing in the Multicenter Automatic Defibrillator Trial II, J Cardiovasc Electrophysiol, 16, 359, 10.1046/j.1540-8167.2005.50038.x Sharma, 2005, Percent right ventricular pacing predicts outcomes in the DAVID trial, Heart Rhythm, 8, 830, 10.1016/j.hrthm.2005.05.015 Olshansky, 2007, Is dual-chamber programming inferior to singlechamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) Study, Circulation, 115, 9, 10.1161/CIRCULATIONAHA.106.629428 Swedberg, 2005, The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology, Eur Heart J, 26, 1115, 10.1093/eurheartj/ehi204 Kindermann, 2006, Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE), J Am Coll Cardiol, 47, 1927, 10.1016/j.jacc.2005.12.056 Doshi, 2005, Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study), J Cardiovasc Electrophysiol, 16, 1160, 10.1111/j.1540-8167.2005.50062.x Cleland, 2005, The effect of cardiac resynchronization on morbidity and mortality in heart failure, N Engl J Med, 352, 1539, 10.1056/NEJMoa050496 Bleeker, 2006, Cardiac resynchronization therapy in patients with narrow QRS, J Am Coll Cardiol, 48, 2243, 10.1016/j.jacc.2006.07.067 Marchlinski, 1988, Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator, Am J Cardiol, 62, 393, 10.1016/0002-9149(88)90965-4 Theuns, 2005, Defibrillation efficacy testing: long-term follow-up and mortality, Europace, 7, 509, 10.1016/j.eupc.2005.04.005 Gold, 2002, Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS), Circulation, 105, 2043, 10.1161/01.CIR.0000015508.59749.F5 Strickberger, 2004, Is defibrillation testing required for defibrillator implantation?, J Am Coll Cardiol, 44, 88, 10.1016/j.jacc.2003.11.068 Chen, 1998, Current concepts of ventricular fibrillation, J Cardiovasc Electrophysiol, 9, 553, 10.1111/j.1540-8167.1998.tb01848.x Russo, 2005, Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?, Heart Rhythm, 2, 456, 10.1016/j.hrthm.2005.01.015 Leong-Sit, 2006, Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation, Am Heart J, 152, 1104, 10.1016/j.ahj.2006.06.025 Singer, 1992, Defibrillation Threshold: clinical utility and therapeutic implications, Pacing Clin Electrophysiol, 15, 932, 10.1111/j.1540-8159.1992.tb03083.x Gliner, 1990, The defibrillation success rate versus energy relationships: Part I-curve fitting and the most efficient defibrillation energy, Pacing Clin Electrophysiol, 13, 326, 10.1111/j.1540-8159.1990.tb02046.x Swerdllow, 2007, The dilemma of ICD implanting testing, Pacing Clin Electrophysiol, 30, 675, 10.1111/j.1540-8159.2007.00730.x Chen, 1986, Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability, Circulation, 73, 1022, 10.1161/01.CIR.73.5.1022 Swerdlow, 2001, Implantation of cardioverter defibrillators without induction of ventricular fibrillation, Circulation, 103, 2159, 10.1161/01.CIR.103.17.2159 Swerdlow, 1996, Comparative reproducibility of defibrillation threshold and upper limit of vulnerability, Pacing Clin Electrophysiol, 19, 2103, 10.1111/j.1540-8159.1996.tb03285.x Kirilmaz, 2005, Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillation implantation, Pacing Clin Electrophysiol, 28, 498, 10.1111/j.1540-8159.2005.50008.x Swerdlow, 1996, Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter defibrillators, J Am Coll Cardiol, 27, 1112, 10.1016/0735-1097(95)00603-6 Swerdlow, 1997, Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability, Circulation, 95, 1497, 10.1161/01.CIR.95.6.1497 Strickberger, 1996, Clinical predictors of defibrillation energy requirements in patients treated with a non-thoracotomy defibrillator system, Am Heart J, 131, 257, 10.1016/S0002-8703(96)90350-6 Espstein, 1992, Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study, Circulation, 86, 1206, 10.1161/01.CIR.86.4.1206 Shukla, 2003, High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications, Pacing Clin Electrophysiol, 26, 44, 10.1046/j.1460-9592.2003.00148.x Hodgson, 2002, Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system, Pacing Clin Electrophysiol, 25, 408, 10.1046/j.1460-9592.2002.00408.x Rashba, 2003, Distal right ventricular coil position reduces defibrillation thresholds, J Cardiovasc Electrophysiol, 14, 1036, 10.1046/j.1540-8167.2003.03205.x Kroll, 2006, Present understanding of shock polarity for internal defibrillation: The obvious and non obvious clinical implications, Pacing Clin Electrophysiol, 29, 885, 10.1111/j.1540-8159.2006.00456.x Ellembogen, 1992, Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias, Am J Cardiol, 70, 1017, 10.1016/0002-9149(92)90353-Z Leitch, 1990, Correlation between the ventricular electrogram amplitude in sinus rhythm and in ventricular fibrillation, Pacing Clin Electrophysiol, 13, 1105, 10.1111/j.1540-8159.1990.tb02166.x Dekker, 2004, Undersensing of VF in a patient with optimal R wave sensing during sinus rhythm, Pacing Clin Electrophysiol, 27, 833, 10.1111/j.1540-8159.2004.00542.x Schuger, 2006, Defibrillation energy requirements in an ICD population receiving cardiac resyncronization therapy, J Cardiovasc Electrophysiol, 17, 247, 10.1111/j.1540-8167.2006.00345.x Tokano, 1998, Effect of ventricular shock strength on cardiac hemodynamics, J Cardiovasc Electrophysiol, 9, 791, 10.1111/j.1540-8167.1998.tb00118.x Alter, 2005, Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients, Pacing Clin Electrophysiol, 28, 926, 10.1111/j.1540-8159.2005.00195.x Frame, 1993, Initial experience with transvenous implantable cardioverter defibrillator lead systems: operative morbidity and mortality, Pacing Clin Electrophysiol, 16, 149, 10.1111/j.1540-8159.1993.tb01552.x Mitchell, 2002, Sudden death in patients with implantable defibrillators: the importance of post-shock electromechanical dissociation, J Am Coll Cardiol, 39, 1323, 10.1016/S0735-1097(02)01784-9 Swerdlow, 2004, Reappraisal of implant testing of implantable cardioverters defibrillators, J Am Coll Cardiol, 44, 92, 10.1016/j.jacc.2004.04.017 Strickberger, 2004, Is defibrillation testing required for defibrillation implantation?, J Am Coll Cardiol, 44, 88, 10.1016/j.jacc.2003.11.068 Gold, 1997, Complications associated with pectoral implantation of cardioverter defibrillators. WorldWide Jewel Investigators, Pacing Clin Electrophysiol, 20, 208, 10.1111/j.1540-8159.1997.tb04844.x Strickberger, 1995, Comparison of implantation of nonthoracotomy defibrillators in the operating room versus the electrophysiology laboratory, Am J Cardiol, 75, 255, 10.1016/0002-9149(95)80031-M Reynolds, 2006, The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators, J Am Coll Cardiol, 47, 2493, 10.1016/j.jacc.2006.02.049 Alter, 2005, Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients, Pacing Clin Electrophysiol, 28, 926, 10.1111/j.1540-8159.2005.00195.x Uslan, 2006, Cardiac device infections: getting to the heart of the matter, Curr Opin Infect Dis, 19, 345, 10.1097/01.qco.0000235160.78302.24 Thompson, 1988, Fibrin glue: a review of its preparation, efficacy, and adverse effects as a topical hemostat, Drug Intell Clin Pharm, 22, 946, 10.1177/106002808802201203 Mela, 2001, Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants, Am J Cardiol, 88, 750, 10.1016/S0002-9149(01)01845-8 Smith, 1998, Infections with nonthoracotomy implantable cardioverter defibrillators: can these be prevented? Endotak Lead Clinical Investigators, Pacing Clin Electrophysiol, 21, 42, 10.1111/j.1540-8159.1998.tb01060.x Voigt, 2006, Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003, J Am Coll Cardiol, 48, 590, 10.1016/j.jacc.2006.05.016 Da Costa, 1998, Role of the preaxillary flora in pacemaker infections: a prospective study, Circulation, 97, 1791, 10.1161/01.CIR.97.18.1791 Sohail, 2007, Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections, J Am Coll Cardiol, 49, 1851, 10.1016/j.jacc.2007.01.072 Chamis, 2001, Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators, Circulation, 104, 1029, 10.1161/hc3401.095097 Del Rio, 2003, Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome, Chest, 124, 1451, 10.1378/chest.124.4.1451 Ruttmann, 2006, Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis, Pacing Clin Electrophysiol, 29, 231, 10.1111/j.1540-8159.2006.00328.x Wiegand, 2004, Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy, Chest, 126, 1177, 10.1378/chest.126.4.1177 Michaud, 2000, A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation, J Am Coll Cardiol, 35, 1915, 10.1016/S0735-1097(00)00633-1 Goldstein, 1998, Outpatient pacemaker procedures in orally anticoagulated patients, Pacing Clin Electrophysiol, 21, 1730, 10.1111/j.1540-8159.1998.tb00271.x Al-Khadra, 2003, Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients, Pacing Clin Electrophysiol, 26, 511, 10.1046/j.1460-9592.2003.00084.x Milic, 2005, Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment, Europace, 7, 374, 10.1016/j.eupc.2005.03.007 Magney, 1993, Anatomical mechanisms explaining damage to pacemaker leads, defibrillator leads, and failure of central venous catheters adjacent to the sternoclavicular joint, Pacing Clin Electrophysiol, 16, 445, 10.1111/j.1540-8159.1993.tb01607.x Shimada, 1999, Percutaneous cephalic vein approach for permanent pacemaker implantation, Pacing Clin Electrophysiol, 22, 1499, 10.1111/j.1540-8159.1999.tb00354.x Lickfett, 2004, Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement, Europace, 6, 25, 10.1016/j.eupc.2003.09.001 Oginosawa, 2002, The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads, Pacing Clin Electrophysiol, 25, 1605, 10.1046/j.1460-9592.2002.01605.x Korkeila, 2006, Transesophageal echocardiography in the diagnosis of thrombosis associated with permanent transvenous pacemaker electrodes, Pacing Clin Electrophysiol, 29, 1245, 10.1111/j.1540-8159.2006.00519.x Jung, 1995, Randomized comparison of aspirin and phenprocoumon for prevention of right-sided thromboembolic complications associated with transvenous defibrillation leads, Eur Heart J, 16, 986, 10.1093/oxfordjournals.eurheartj.a061035 Seeger, 1986, Asymptomatic pulmonary embolism following pacemaker implantation, Pacing Clin Electrophysiol, 9, 196, 10.1111/j.1540-8159.1986.tb05392.x Krishnan, 2006, Recurrent postcardiac injury syndrome mimicking cardiac perforation following transvenous pacing: An unusual presentation, Pacing Clin Electrophysiol, 29, 1312, 10.1111/j.1540-8159.2006.00539.x Mahapatra, 2005, Incidence and predictors of cardiac perforation after permanent pacemaker placement, Heart Rhythm, 2, 907, 10.1016/j.hrthm.2005.06.011 Sivakumaran, 2002, Postpacemaker implant pericarditis: incidence and outcomes with active-fixation leads, Pacing Clin Electrophysiol, 25, 833, 10.1046/j.1460-9592.2002.t01-1-00833.x Hirschl, 2007, Prevalence and characterization of asymptomatic pacemaker and ICD lead perforation on CT, Pacing Clin Electrophysiol, 30, 28, 10.1111/j.1540-8159.2007.00575.x Geyfman, 2007, Cardiac tamponade as complication of active-fixation atrial lead perforations: proposed mechanism and management algorithm, Pacing Clin Electrophysiol, 30, 498, 10.1111/j.1540-8159.2007.00699.x Trehan, 2005, Nonsurgical management of cardiac tamponade caused by a temporary pacemaker lead, Pacing Clin Electrophysiol, 28, 242, 10.1111/j.1540-8159.2005.09503.x Alonso, 2001, Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects, Heart, 86, 405, 10.1136/heart.86.4.405 Bristow, 2004, Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, N Engl J Med, 350, 2140, 10.1056/NEJMoa032423 Albertsen, 2005, Left ventricular lead performance in cardiac resynchronization therapy: impact of lead localization and complications, Pacing Clin Electrophysiol, 28, 483, 10.1111/j.1540-8159.2005.40066.x De Martino, 2005, A randomized evaluation of different approaches to coronary sinus venography during biventricular pacemaker implants, Europace, 7, 73, 10.1016/j.eupc.2004.09.006 Leon, 2005, Practical approach to implanting left ventricular pacing leads for cardiac resynchronization, J Cardiovasc Electrophysiol, 16, 100, 10.1046/j.1540-8167.2005.04600.x Romeyer-Bouchard, 2005, Simplified cardiac resynchronization implantation technique involving right access and a triple-guide/single introducer approach, Heart Rhythm, 2, 714, 10.1016/j.hrthm.2005.04.005 Grimm, 1999, Complications of third-generation implantable cardioverter defibrillator therapy, Pacing Clin Electrophysiol, 22, 206, 10.1111/j.1540-8159.1999.tb00334.x Miracapillo, 2006, Early mobilization after pacemaker implantation, J Cardiovasc Med (Hagerstown), 7, 197, 10.2459/01.JCM.0000215273.70391.bf